The Global HIV Enterprise, the National Institute of Allergy and Infectious Diseases (NIAID), and the HIV Mucosal Immunology Group (MIG)gratefully acknowledge the contributions of the many experts who responded to requests for concepts, content, references, and comments. We would like to thank them for the practical and essential feedback they provided on prior drafts of the document.